Twist Bioscience ( (TWST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Twist Bioscience’s stock has experienced a downturn despite reporting record revenue growth and improved gross margins. Analysts have lowered price targets due to cautious near-term growth in the SynBio segment and negative insider sentiment, as evidenced by increased share sales. While the NGS and healthcare segments show strong performance, the company is grappling with challenges from customer transitions and stagnant industrial chemical sales. Although Cathie Wood’s ARK Investment’s purchase of additional shares indicates some investor confidence, overall sentiment remains mixed.
More about Twist Bioscience
YTD Price Performance: -39.26%
Average Trading Volume: 1,156,605
Technical Sentiment Signal: Sell
Current Market Cap: $1.66B
For further insights into TWST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.
This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.